Sigyn Therapeutics Inc 's

• RSAP's Stock Performance relative to its Competitors

Aethlon Medical Inc Share Performance -48.68% 30 Days

Aethlon Medical Inc Profile Aethlon Medical Inc's business model revolves around the development and commercialization of innovative therapeutic devices designed to address life-threatening conditions. The company aims to create and market medical solutions that target the removal of disease-causing particles from the circulatory system, with a focus on infectious diseases and cancer. More about Aethlon Medical Inc 's Market Share

Caribou Biosciences Inc Share Performance -15.19% Over The Past 5 Days

Caribou Biosciences Inc Profile Caribou Biosciences Inc is a biotechnology company that focuses on the development of gene editing technologies. Their business model involves licensing their proprietary CRISPR-Cas9 platform and collaborating with partners to advance research and therapeutic applications in various industries. More about Caribou Biosciences Inc 's Market Share

Alpha Tau Medical Ltd Share Performance +270.90% One Year

Alpha Tau Medical Ltd Profile Alpha Tau Medical Ltd's business model revolves around developing and commercializing targeted alpha therapy (TAT) for the treatment of cancer. More about Alpha Tau Medical Ltd's Market Share

Iovance Biotherapeutics inc Share Performance -6.38% Over The Past 5 Days

Iovance Biotherapeutics inc Profile Iovance Biotherapeutics Inc operates on a business model centered around developing and commercializing novel cancer immunotherapy treatments. The company focuses on utilizing its proprietary Tumor Infiltrating Lymphocyte (TIL) therapy, which involves collecting and expanding a patient's own immune cells to target and kill cancer cells. Iovance primarily seeks to advance its TIL therapy candidates through clinical trials and collaborations while aiming to provide effective and personalized treatment options for cancer patients. More about Iovance Biotherapeutics inc 's Market Share

Sources: Sigyn Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Tuesday, September 8, 2026 1:52 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Sigyn Therapeutics Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.